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Validation of a new simple questionnaire to
“estimate ambulation capacity by history”
(EACH) in patients with claudication
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Georges Leftheriotis, MD, PhD,a,b,c and Pierre Abraham, MD,a,b,c Angers, France
Objectives: The assessment of walking limitation is important in determining the severity of many diseases, including
peripheral artery disease. Questionnaires exist for estimating walking capacity, but these have limited use in routine
clinical practice. We sought to establish the feasibility and validity of the estimating ambulation capacity by history
questionnaire (EACH-Q), a self-administered, four-item questionnaire that estimates walking capacity in patients
reporting vascular-type claudication.
Background: The EACH-Q estimates the maximal duration that can be attained (eight possibilities: from impossible to 3
hours or more) at four different displacement speeds (from slow walking to running). Scores can be obtained easily by
multiplying the rank of each possible answer (impossible being zero) by a speed factor.
Methods: The Walking Impairment Questionnaire (WIQ) and the EACH-Q were completed by 218 patients with
vascular-type claudication, undergoing treadmill exercise testing. We hypothesized that less errors (ie, missing, dupli-
cated, or paradoxical answers) and missing final scores would be observed for the EACH-Q than the WIQ. Validity was
assessed by calculating correlation coefficients (r) between the questionnaire scores (both questionnaires, noncorrected
and corrected) and treadmill maximal walking distance (MWD: 3.2 km/h, 10% slope, maximized to 15 minutes).
Results: Compared with the EACH-Qs, nearly twice as many WIQs had to be corrected for one or more errors (52% vs
28%; P < .0001). This resulted in 37 (17%) WIQ versus 18 (8%) EACH-Q scores being missing on noncorrected
questionnaires (P < .0001). MWD was 162 m (25-75° percentiles: 91-390 m). The correlation coefficients of WIQ and
EACH-Q to MWD were 0.59 and 0.52, respectively, before correction (P  .357) and 0.60 and 0.51, respectively, after
correction (P  .185).
Conclusions: The EACH-Q is a simple and valid questionnaire for estimating walking capacity in patients with
vascular-type claudication. It is easily scored. It might help standardize the reporting of how patients feel about their
walking limitation. Further research is needed to validate the EACH-Q in other patient groups and against other
treadmill protocols and to assess its reliability and sensitivity. ( J Vasc Surg 2011;54:133-8.)
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FThe maximal walking distance (MWD), the distance at
which pain forces the patient to stop walking, is of great
importance for assessing the severity of claudication in
patients with lower extremity arterial disease (LEAD). Pa-
tient interview is the most readily accessible way of estimat-
ing walking capacity in routine clinical practice, although
patients suffering with LEAD typically estimate their walk-
ing capacity poorly.1 Opened questions without guided
answers about the distance estimated by the patient before
limb pain or discomfort forces to stop walking, lack stan-
dardization. A question such as “Because of a health or
physical problem, do you have any difficulty walking for
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doi:10.1016/j.jvs.2010.11.129ne mile?”2 only allows for a yes/no response. The func-
ional status component of the 86-item PAVK-86 ques-
ionnaire estimates MWD,3,4 but the PAVK-86 is a time-
onsuming tool. The walking impairment questionnaire
WIQ)5-7 was proposed a decade ago to standardize the
stimation of walking capacity by patient interview and is
argely used. Unfortunately, the WIQ is also relatively
omplex (14 items with five possible answers for each item:
0 boxes), which often results in a high number of errors
hen self-completed by the patient.8 Furthermore, the
IQ score is difficult to obtain by mental calculation or
ithout the use of a computer.
Our goal was to test the validity of a new simple
our-item questionnaire, the EACH-Q, for “Estimating
mbulation Capacity by History” in patients complaining
f vascular-type claudication. We hypothesized that: (1) a
elf-completed EACH-Q would have fewer errors than a
elf-completed WIQ; and, (2) these two questionnaires
ould show comparable concordances with treadmill
WD.
ETHODS
Study population. A prospective study on all new
rench language-speaking patients referred to our labora-
ory for vascular-type claudication was performed. Claudi-
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July 2011134 Ouedraogo et alcation is of vascular type (ie, suspected of arterial origin)
when pain or discomfort occurs at exercise and is improved
within 10 minutes when exercise is stopped. Most patients
had, or were suspected to have, peripheral artery disease
(PAD). Evidence for PAD was based on the presence of at
least one of the following criteria: a history of revascular-
ization (surgery or angioplasty) for PAD; a previous ultra-
sound or radiological investigation showing stenosis/oc-
clusion of the aortoiliac and/or lower-limb arteries; an
ankle-to-brachial index (ABI) at rest 0.90 on one or both
legs. Patients who were referred more than once during the
study period had only their first visit included. This study
received local ethics committee approval and conforms to
the Declaration of Helsinki. Written, informed consent was
provided by patients prior to their participation. The study
is accessible on the http://clinicaltrials.gov web site under
reference NCT01114178. On arrival at the laboratory,
patients were asked to complete (without help) the
EACH-Q and WIQ using a black or blue pen. The patients
were not aware of which was the new questionnaire.
Design of the EACH-Q. The EACH-Q was de-
signed with the assumption that, since many patients have a
watch and may have measured their true walking time,
using maximal estimated time rather than maximal esti-
mated distance would facilitate patients’ reporting of their
walking capacity and thereby reduce the number of missing
answers. Furthermore, we used the three following obser-
vations:
1) Patients suffering claudication might show different
walking capacities (in time or distance) if they walk fast
Fig 1. English translationor slow. Therefore, the new questionnaire was con- tstructed to assess estimated maximum exercise duration
for different displacement speeds.
) At a constant load, the walking distance in claudicating
patients follows a log-normal distribution.9 Thus, the
possible exercise durations proposed for each displace-
ment speed were defined such that they follow an
exponential increase.
) There is an inverse exponential relationship between
MWD and walking speed in patients with claudica-
tion.10 Therefore, the values attributed to the different
displacement speeds in the new questionnaire were
defined so that they follow an exponential increase.
Last, our aim was that scoring of a questionnaire should
e easy to remember and possible without the use of a
omputer program.
The original EACH-Q used in this study is in French,
ut an English translation is presented in Fig 1. The
ACH-Q includes four items, each one representing a
ifferent displacement speed. For each item, the patient was
sked to choose the longest duration that could be per-
ormed easily among the durations proposed. As shown for
ach item, if the answer was not “impossible,” the dura-
ions followed an exponential increase from 30 seconds to 3
ours.
Each duration was attributed a value consistent with its
osition among the possible responses (eg, 0 for “impossi-
le,” 1 for “30 seconds,” and 7 for “3 hours or more”).
ach displacement speed was attributed a coefficient, and a
core was calculated for each displacement speed by multi-
lying the corresponding coefficient by the value attributed
e EACH Questionnaire.o the duration response. These coefficients for each item
t
t
b
s
2
c
f
m
l
o
p
c
T
c
t
l
s
r
p
b
c
F
t
w
l
i
C
i
a
n
e
k
t
d
d
b
7
n
w
s
l
e
S
2
b
n
s

t
l
W
t
W
q
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 1 Ouedraogo et al 135were fixed “a priori” before the study, but the primary goal
was to have a maximal possible EACH-Q score of 100 and
an exponential increase of the coefficients. Since the maxi-
mal value of the answers to each item was 7, then the sum of
coefficients had to be 14.286: 7 14.286 100. We then
used the following coefficients: 1 for “slow walk,” 2 for
“normal walk,” 4 for “fast walk,” and 7.286 for “run.”
Although arbitrarily fixed, these coefficient fit an exponen-
tial increase (r .999). For the 7.286 speed coefficient, the
eight possible products were rounded to the nearer whole
number giving the following possible values: 0, 7, 15, 22,
29, 36, 44, and 51. The total EACH-Q score was the sum
of the calculated scores for all displacement speeds divided
by 100, since, by construction, the maximal possible score
is 100 ( [1 7] [2 7] [4 7] [7.286 7]). For
example, a patient reporting 30 minutes at a slow walking
speed, 10 minutes at a normal walking speed, 1 minute at a
fast walking speed, and impossible for running would score
21% ( [1 5] [2 4] [4 2] [7.286 0])/100.
For noncomplete, noncorrected EACH-Qs, paradoxi-
cal answers (eg, higher duration at higher displacement
speed) were left unchanged; for duplicate answers (two or
more answers for the same question), the shorter duration
was used; missing (no answer to a question) answers were
considered “impossible” for the running question only and
left unchanged for other items. Then, the score was calcu-
lated when at least two items were available (by dividing the
sum of points of the available items by the maximum
possible score for these items and multiplying by 100).
Thereafter, the questionnaire was checked for completion
and errors by a technician or nurse before the treadmill test.
Missing, duplicate, and paradoxical answers were discussed
with the patient and corrected. For a missing answer, if the
patients were unable to predict what they could manage if
they had to perform the task, the response was declared
“impossible.” For duplicate answers, if the patient was
unable to choose, the lower duration was arbitrarily kept.
For paradoxical answers, the patient was asked to correct his
or her answers after having it explained to him or her that
the answers were expected to follow a logical order with
unchanged or decreased maximal time for an increase in
speed displacement. Corrections were made with a red pen
to allow us to easily identify corrected and noncorrected
questionnaires. Once corrections were made, a new scoring
of the corrected questionnaire was done.
WIQ. We used the French version of the WIQ, as
previously reported.11 Self-completed WIQs were scored as
previously described.7 In brief, each response is attributed a
value ranging from 0 (impossible) to 4 (no difficulty). For
the distance subscale, each distance is attributed a weight
ranging from 20 to 1500. For each distance proposed, the
product of weight by the answer value is calculated, and the
subscale score is the sum of these products divided by
14,080 (maximal possible result). For the speed subscale,
each speed is attributed a weight (ranging from 1.5 to 5).
The product of weight by the answer value is calculated for
each question, and the speed subscale score is the sum of
these products divided by 46 (maximal possible result). For bhe stair climbing subscale, weights are 12 for one, 24 for
wo, and 36 for three flights of stairs. The product of weight
y the answer value is calculated and the stair-climbing
ubscale score is the sum of these products divided by
88 (maximal possible result). For noncomplete, non-
orrected WIQs, paradoxical answers were left unchanged;
or duplicate answers, the highest difficulty was used; for
issing answers, a subscale score was calculated when at
east half of the answers were available (by dividing the sum
f the points of available answers by the maximum possible
oint score for these answers); and the total WIQ score was
alculated when at least two subscale scores were available.
hereafter, as for the EACH-Q, the WIQ was checked for
ompletion and errors by a technician or nurse before the
readmill test. Missing, duplicate, and paradoxical (eg,
ower difficulty for higher distance or higher number of
tairs) answers were discussed with the patient and cor-
ected. For a missing answer, if the reason was “I never
erform such a task,” the response was declared “impossi-
le.” For duplicate answers, if the patient was unable to
hoose, the higher level of difficulty was arbitrarily kept.
or paradoxical answers, the patients were asked to correct
heir answers after being explained to that the answers
ithin a subscale of the WIQ were expected to follow a
ogical order with unchanged or increasing difficulty for
ncrease in task level (speed, distance, or number of stairs).
orrections were made with a red pen to allow us to easily
dentify corrected and noncorrected questionnaires. There-
fter, as for the EACH-Q, once corrections were made, a
ew scoring of corrected WIQs was done.
Walking capacity on treadmill. The treadmill gradi-
nt was set at 10%. The speed was increased from 0 to 3.2
m/hour within 1 minute (to allow the patient to adapt to
readmill walking) and then stabilized for a maximum
uration of 15 minutes, which corresponds to a maximum
istance of 750 meters. This maximal distance was chosen
ecause we have previously shown that, after reaching the
50 meter mark,10% of patients stop walking within the
ext 250 meters.9 Before the treadmill test, each patient
as informed that the test could be stopped whenever
ymptoms (eg, claudication, breathlessness, nonischemic
eg pain) became intolerable. The MWD was recorded for
ach patient.
Sample size calculation and statistical analyses.
ample size calculation was based on the estimation that
5% of the WIQs and only 12.5% of EACH-Qs could not
e scored as a result of missing answers. A minimal
umber of 155 participants was required to search for a
ignificant difference between these two proportions for
 0.05 and 90% power. For practical reasons, in perspec-
ive of the number of new patients that are referred to the
aboratory, a 6-month study period was used.
Results are reported as mean  SD except for MWD,
IQ, and EACH-Q scores, which were nonnormally dis-
ributed and thus presented as median (25-75 percentiles).
e used a McNemar test to identify if the proportion of
uestionnaires with errors or unavailable scores differed
etween the WIQ and the EACH-Q before correction.
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result in a missing score. We calculated the Spearman “r”
coefficient of correlation between the questionnaire scores
(both questionnaires, noncorrected and corrected) and
MWD. Statistical analyses were performed using SPSS ver-
sion 15.0 (SPSS, Chicago, Ill). For all tests, a two-tailed
P  .05 was used to indicate statistical significance.
RESULTS
Population studied. During the study period, as a
result of an increased activity in the laboratory, 219 patients
with claudication were referred for treadmill testing. One
patient refused to participate. Of the remaining 218 pa-
tients, 178 (82%) were male, and the average age, body
mass, height, and body mass index was 62 11 years, 77
14 kg, 1.70 0.08 meters, and 26.6 4.5 kg/m
2
, respec-
tively. ABI was nonmeasurable on both sides in four pa-
tients. Brachial artery systolic and diastolic pressures were
135  20 mm Hg and 78  9 mm Hg, respectively. The
ABI (lowest of left and right sides) was 0.81  0.25.
Among studied patients, 180 (82.6%) were proved to have
PAD. Among the other 38 patients, nine were later proved
to have isolated buttock exercise-induced ischemia. Treat-
ments included antiplatelet or anticoagulant (n  161),
beta blockers (n  61), antidiabetic drugs or insulin (n 
41), cholesterol-lowering drugs (n  134), antihyperten-
sive (n  130), analgesic or anxiolytic drugs (n  58), and
other drugs (n  130).
Completion of the questionnaires. Sixty percent of
the patients made at least one error in one or both ques-
tionnaires: 18 on the EACH-Q only, 71 on the WIQ only,
and 42 on both the EACH-Q and the WIQ. As a result, the
proportion of questionnaires with errors was 52% (range,
45%-58%; 113 out of 218) with the WIQ, and 28% (range,
22%-34%; 60 out of 218) with the EACH-Q (P  .0001).
Type of errors. The number of EACH-Qs with miss-
ing, paradoxical, or duplicate answers was 41, 22, and 4,
respectively. The total number of missing, paradoxical, or
duplicate answers for the EACH-Q was 102, 26, and 5,
respectively. The number of WIQs with missing, paradox-
ical, or duplicate answers was 94, 42, and 12, respectively.
The total number of missing, paradoxical, or duplicate
answers for the WIQ was 608, 77, and 13, respectively.
Overall, considering the total number of questions that had
to be completed and that multiple errors could be made
within one item, we observed 133 errors of a possible 872
(15%) with the EACH-Q and 698 errors of a possible 3052
(23%) with the WIQ (P  .0001). As a result of missing
values, the distance, speed, and stair-climbing subscores for
the WIQ could only be obtained in 173 (79%), 181 (83%),
and 176 (81%) cases, respectively. This resulted, before
correction of questionnaires, in 37 missing WIQ scores
(17% of WIQ questionnaires), compared with only 18
missing EACH-Q scores: 8% of EACH-Qs (P  .0001).
The distribution of questionnaire scores is presented in
Fig 2. In both cases, scores were not normally distributed.
As shown, the median score with the EACH-Q was 23% (range, 10%-40%). It was lower than the median score of
he WIQ, which was 41% (range, 26%-61%; P  .001).
Treadmill MWD. Treadmill median MWD was 162
eters (25°-75° percentiles: 91-390 meters). The distribu-
ion of MWD observed on treadmill is reported in Fig 3.
hirty-one (14%) of the patients completed the test. The
readmill test evoked lower-limb claudication in 184 of the
18 patients (84%), among which 17 completed the test
espite claudication. Twenty (9%) patients had to stop the
est for nonlimb symptoms, mainly dyspnea. Fourteen (6%)
atients completed the test without claudication.
Correlation of questionnaire scores to treadmill
WD. The relationships between questionnaire scores
nd MWD were moderate, ranging from r .51 to r .60
ig 2. Distribution of the scores for the EACH-Q and the WIQ
y intervals of 10%.
ig 3. Distribution of the walking distances by intervals of 50
eters.Table). There was no significant difference between the
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Volume 54, Number 1 Ouedraogo et al 137correlation coefficients of the questionnaire scores to
MWD (P .357 and P .185) before and after correction,
respectively.
DISCUSSION
When validated against treadmill MWD, the EACH-Q
compares favorably with the WIQ in patients complaining
of vascular-type claudication. However, fewer errors were
made on the EACH-Q, since it is easier to complete. The
EACH-Q also has three other advantages over the WIQ.
First, it includes only four items, thus the time needed for
completion is very short (usually 1-2 minutes). Second, the
EACH-Q integrates the concept that displacement speed
and exercise capacity are inversely related in patients with
LEAD. Third, the scoring is easy, without the need of a
computer.
Our first goal when designing the EACH-Q was for it
to be simple and short, to limit the number of errors made
by patients during self-completion. The EACH-Q has four
questions, each having eight possible answers (for a total of
32 boxes). The WIQ is relatively long in comparison,
having 14 questions each with five possible answers (for a
total of 70 boxes).7 The findings of a meta-analysis of
randomized control trials suggested that shorter question-
naires should be preferred and that reducing the length of
relatively short questionnaires is more effective than reduc-
ing the length of longer questionnaires.12 Reducing the
length of the questionnaire reduces the time needed for com-
pletion and probably increases the response rate (ie, propor-
tion of completed questionnaires).13 The exponential-type
increase in the durations proposed for each displacement
speed seems to facilitate the decision of patients.14 The
lower number of errors of the EACH-Q might be explained
by the use of exponential scales, the limited number of
questions, and the use of maximal time rather than maximal
distance.
Our second goal for the EACH-Q was for it to have a
Table. Spearman rank coefficients of correlation with
treadmill walking distance before and after correction
Questionnaires R n P
Noncorrected WIQ distance
subscore
0.553 173 .001
WIQ speed
subscore
0.515 181 .001
WIQ stair climbing
subscore
0.520 176 .001
Overall WIQ 0.586 181 .001
EACH-Q 0.520 200 .001
Corrected WIQ distance
subscore
0.581 218 .001
WIQ speed
subscore
0.560 218 .001
WIQ stair climbing
subscore
0.448 218 .001
Overall WIQ 0.601 218 .001
EACH-Q 0.513 218 .001
n is the number of available scores.level of validity (ie, the relationship between the question- saire score [estimated walking capacity] and treadmill
WD) comparable to that of the WIQ. Estimation of
alking capacity by history is an easy and low-cost tool for
pidemiologic studies. Furthermore, questionnaires facili-
ate the standardization of patients’ answers in clinical
outine. Previous studies have shown that the relationship
etween questionnaire-based estimates of walking capacity
nd objectively-determined walking capacity is generally
air, both in LEAD and non-LEAD patients.3-5,7,11,15-17
or example, the correlation coefficient (r) between the
verall WIQ score and constant-load treadmill MWD was
hown to be 0.53 for 24 patients with arterial claudica-
ion.11 In another study, Spearman rank correlation coeffi-
ients (rho) between the WIQ distance score and maximum
-minute walking distance were 0.56 among 145 patients
ith LEAD (P  .001) and 0.48 among 65 patients
ithout LEAD (P .001).7 In the same study, correlation
oefficients (r) between the WIQ speed score and the usual
ace 4-meter walking time have also been shown to be 0.53
mong patients with LEAD (P  .001) and 0.52 among
atients without LEAD (P  .001)7. Another study
howed that, of the four WIQ subscales, treadmill MWD
1.5 mph and 10% grade) was only significantly correlated
ith distance (r  .41) and speed (r  .39).5 The correla-
ion coefficients between the EACH-Q scores and tread-
ill MWD were in the same range as the values stated
bove, although it cannot be excluded that the absence of
ifference has resulted from a type II error. Further study is
eeded to assess whether changes in the EACH-Q score
orrelate with changes in objectively measured MWD, as is
he case for the WIQ.18 A large prospective study is re-
uired to assess the sensitivity of the EACH-Q to changes
n LEAD severity (as could be estimated through ABI
hanges).
There are some limitations to the present study. First,
lthough many studies in vascular disease include more
ales than females, the proportion of males in our study is
articularly high. The explanation for this is not readily
pparent and might limit the generalization of our findings.
dditional studies are needed in women, other socio-
conomic groups, and other patient groups. Second, due to
he specific interest of our laboratory being proximal and
typical claudication, a large proportion of our patients
xperienced claudication with an apparently normal ABI at
est. This might lead one to question whether some of our
atients did suffer vascular claudication. Therefore, it is
mportant to note that the description of claudication
ymptoms provided by patients was consistent with a vas-
ular origin. Third, the reliability of the EACH-Q requires
esting in a large group of patients. The reliability of the
IQ, as assessed using Cronbach’s alpha, has been re-
orted to be high, in the range 0.92 to 0.9715,19; however,
he Cronbach’s alpha value increases with the number of
tems in the scale,20,21 and it is not robust against missing
ata.21 These two points are of specific interest since the
IQ is longer and suffers a high range of missing data when
elf-completed, than the EACH-Q. Fourth, one could
uggest that the 7.286 speed coefficient is not easy to
11
1
1
1
1
1
1
1
1
2
2
JOURNAL OF VASCULAR SURGERY
July 2011138 Ouedraogo et alremember for a routine use. We found it easy to memorize
this coefficient by using 22/3, which is 7 and one-third.
The numbers of points obtained with 7.333, when
rounded to the nearer whole number, are almost the same
as with 7.286. Fifth, we have no information about the
education, intelligence, socioeconomic status, or func-
tional level of the patients. Nevertheless, this was expected
to be of little influence since we compared the question-
naires in the same population. Last, we did not specifically
assess for the presence of other conditions that may impair
walking (such as osteoarthritis, prior stroke) and would
likely impair running ability.
CONCLUSION
The EACH-Q is short and easy to score, resulting in
10% missing scores when self-completed. Correlation of
the EACH-Q-score with the objective measurement of
MWD on treadmill is comparable to that observed previ-
ously for other questionnaires. Further research is needed
to validate the EACH-Q in other patient groups and
against other treadmill protocols and to assess its reliability
and sensitivity.
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